Mastering biotechnologies and therapeutic innovations

Level base -

Fundamentals of Biology and Biotechnology

Presentation

Why participate?

Acquire and understand the common language used in biotechnology. Gain the keys to understanding biotechnology projects

Training Context:

This training provides a solid foundation for understanding the mechanisms of life and their technological applications. Such knowledge is essential to navigate a rapidly growing field. The course equips participants with the necessary skills to understand the basics of major health innovations in biopharmaceutical development. Join this training to broaden your perspective and stay at the forefront of scientific innovation.

Learning objectives

  • Acquire fundamental concepts of biology and biotechnology
  • Understand the language and key concepts in the field of biotechnology
  • Identify major innovations in the biopharmaceutical sector
  • Grasp biological processes and their application in the development of health technologies

Content

Welcome and participant introductions

Introduction to the fundamentals of biology and biotechnology

  • Basic concepts in biology

  • Classification of living organisms: cells, tissues, organs, and systems

  • Structure and function of macromolecules: DNA, RNA, proteins, lipids, carbohydrates

  • Transcription and translation: how DNA is translated into proteins

  • The cell cycle and its importance in the development of living organisms

Introduction to biotechnology and molecular engineering

  • Main applications in healthcare and bioproduction

  • Basic techniques: cloning, mutagenesis

  • Protein production and cell culture

  • Key steps: from gene expression to purification

  • Expression systems and introduction to cell culture

Introduction to CRISPR-Cas9

  • History of its discovery

  • Principle of CRISPR-Cas9

  • Applications (fundamental research, genome editing, therapies)

Development cycle of a biopharmaceutical

  • Definition of biopharmaceuticals: therapeutic proteins (therapeutic antibodies), vaccines, and advanced therapy medicinal products (cell and gene therapies)

  • Key stages: research, clinical trials, production, market approval

  • Main stakeholders in the sector

  • The biopharmaceutical market at national and European level

General discussion, conclusion, and evaluation

Teaching methods

Interactive Teaching, Case Studies, Experience Sharing

Audience

Non-scientific professionals, newcomers to the biotechnology sector, or anyone wishing to acquire a solid foundation in biology and biotechnology

Prerequisites

No prerequisites required

Duration

1 day, 7 hours

Price

750 € HT (Public)
600 € HT (Membre)
300 € HT (Académique)

Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.

Sessions

No session available

Rating

There is no rating available because this training session was never carried out.

The benefits of our courses

  • Personalized support
  • Skills assessment
  • Certificate of completion
  • Training quality evaluation
  • Accessible to people with disabilities (please contact us)

How to access and deadlines

Registering online or by e-mail is a pre-registration. We will process your request within one week:

  • Contact by e-mail or telephone
  • Sending of administrative and educational documents: training agreement, training programme and positioning questionnaire.

Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.

When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.

For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr

Jean-Roch Fabreguettes

MEARY

Directeur Médical et Personne Responsable du Centre MEARY de thérapie cellulaire et génique au sein de l’hôpital Saint-Louis à Paris

Jean-Roch Fabreguettes est un spécialiste de la recherche translationnelle et des phases précoces de développement clinique des médicaments de thérapie innovantes (MTI). Pharmacien, titulaire d’un doctorat de l’Université de Montpellier 1, il a travaillé plus de 25 ans dans le domaine et a contribué, pour des équipes académiques comme pour des start-ups, à la réalisation de plus de 30 programmes de recherche sur différents types de MTI : thérapie génique in vivo ou ex vivo, thérapie cellulaire, ingénierie tissulaire… Il est actuellement Directeur Médical et Personne Responsable du Centre MEARY de thérapie cellulaire et génique au sein de l’hôpital Saint-Louis à Paris. Le centre MEARY est une plateforme de l’Assistance Publique – Hôpitaux de Paris (AP-HP), dédiée à la fabrication de médicament de thérapie innovante expérimentaux. Laboratoire membre de l’ISCT, il est autorisé par l’ANSM et dispose d’un certificat GMP. A ce titre Jean-Roch Fabreguettes est impliqué dans le développement clinique et la fabrication de nombreux MTI : CAR-T cells, lymphocytes T régulateurs, cellules stromales mésenchymateuses…

Précédemment, Jean-Roch Fabreguettes a été expert Qualité (CMC) auprès de l’ANSM durant 9 ans et a conseillé différentes sociétés de biotechnologies. Il est un intervenant régulier pour l’Université Paris Cité et un membre actif de l’ISCT et de réseaux nationaux et internationaux sur les MTI (UNI-TC, Join4ATMP).